These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 16357997

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antineoplastic agents. 565. Synthesis of combretastatin D-2 phosphate and dihydro-combretastatin D-2.
    Pettit GR, Quistorf PD, Fry JA, Herald DL, Hamel E, Chapuis JC.
    J Nat Prod; 2009 May 22; 72(5):876-83. PubMed ID: 20161135
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
    Pirali T, Busacca S, Beltrami L, Imovilli D, Pagliai F, Miglio G, Massarotti A, Verotta L, Tron GC, Sorba G, Genazzani AA.
    J Med Chem; 2006 Aug 24; 49(17):5372-6. PubMed ID: 16913727
    [Abstract] [Full Text] [Related]

  • 5. Synthesis of biologically active polyphenolic glycosides (combretastatin and resveratrol series).
    Orsini F, Pelizzoni F, Bellini B, Miglierini G.
    Carbohydr Res; 1997 Jun 20; 301(3-4):95-109. PubMed ID: 9232838
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and evaluation of double bond substituted combretastatins.
    Hadfield JA, Gaukroger K, Hirst N, Weston AP, Lawrence NJ, McGown AT.
    Eur J Med Chem; 2005 Jun 20; 40(6):529-41. PubMed ID: 15922837
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological activity of mustard derivatives of combretastatins.
    Coggiola B, Pagliai F, Allegrone G, Genazzani AA, Tron GC.
    Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3551-4. PubMed ID: 15963722
    [Abstract] [Full Text] [Related]

  • 8. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
    Siles R, Ackley JF, Hadimani MB, Hall JJ, Mugabe BE, Guddneppanavar R, Monk KA, Chapuis JC, Pettit GR, Chaplin DJ, Edvardsen K, Trawick ML, Garner CM, Pinney KG.
    J Nat Prod; 2008 Mar 01; 71(3):313-20. PubMed ID: 18303849
    [Abstract] [Full Text] [Related]

  • 9. Novel combretastatin analogues endowed with antitumor activity.
    Simoni D, Romagnoli R, Baruchello R, Rondanin R, Rizzi M, Pavani MG, Alloatti D, Giannini G, Marcellini M, Riccioni T, Castorina M, Guglielmi MB, Bucci F, Carminati P, Pisano C.
    J Med Chem; 2006 Jun 01; 49(11):3143-52. PubMed ID: 16722633
    [Abstract] [Full Text] [Related]

  • 10. A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent.
    Kong Y, Wang K, Edler MC, Hamel E, Mooberry SL, Paige MA, Brown ML.
    Bioorg Med Chem; 2010 Jan 15; 18(2):971-7. PubMed ID: 20006519
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmaceutical design of antimitotic agents based on combretastatins.
    Hsieh HP, Liou JP, Mahindroo N.
    Curr Pharm Des; 2005 Jan 15; 11(13):1655-77. PubMed ID: 15892667
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and antimicrotubule activity of combretatropone derivatives.
    Janik ME, Bane SL.
    Bioorg Med Chem; 2002 Jun 15; 10(6):1895-903. PubMed ID: 11937347
    [Abstract] [Full Text] [Related]

  • 14. Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
    Pettit GR, Melody N, Thornhill A, Knight JC, Groy TL, Herald CL.
    J Nat Prod; 2009 Sep 15; 72(9):1637-42. PubMed ID: 19719153
    [Abstract] [Full Text] [Related]

  • 15. Structure-based discovery of a boronic acid bioisostere of combretastatin A-4.
    Kong Y, Grembecka J, Edler MC, Hamel E, Mooberry SL, Sabat M, Rieger J, Brown ML.
    Chem Biol; 2005 Sep 15; 12(9):1007-14. PubMed ID: 16183025
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxicity studies of novel combretastatin and pterostilbene derivatives.
    Jakubowska J, Mikuła-Pietrasik J, Książek K, Krawczyk H.
    Biomed Res Int; 2014 Sep 15; 2014():320895. PubMed ID: 25157353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
    Monk KA, Siles R, Hadimani MB, Mugabe BE, Ackley JF, Studerus SW, Edvardsen K, Trawick ML, Garner CM, Rhodes MR, Pettit GR, Pinney KG.
    Bioorg Med Chem; 2006 May 01; 14(9):3231-44. PubMed ID: 16442292
    [Abstract] [Full Text] [Related]

  • 19. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.
    Pettit GR, Singh SB, Hamel E, Lin CM, Alberts DS, Garcia-Kendall D.
    Experientia; 1989 Feb 15; 45(2):209-11. PubMed ID: 2920809
    [Abstract] [Full Text] [Related]

  • 20. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK.
    J Med Chem; 2005 Jun 16; 48(12):4087-99. PubMed ID: 15943482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.